Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ARS Pharmaceuticals Inc SPRY

Healthcare Biotechnology
ARS Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing neffy, for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, administered and... see more

Recent & Breaking News (NDAQ:SPRY)

SHAREHOLDER ALERT: BMRN HMLP SBTX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Accesswire November 11, 2021

INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile November 11, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of FB, CEI and SBTX

Accesswire November 11, 2021

SILVERBACK THERAPEUTICS, INC. (SBTX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Regarding Silverback Therapeutics, Inc.

Newsfile November 11, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HNST, FB and SBTX

Accesswire November 11, 2021

CLASS ACTION UPDATE for HNST, INNV and SBTX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire November 11, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ZEV, HEPS and SBTX

Accesswire November 10, 2021

Silverback Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update

Business Wire November 10, 2021

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile November 10, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FB, ONTF and SBTX

Accesswire November 10, 2021

SBTX DEADLINE: Silverback Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

PR Newswire November 10, 2021

SBTX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Silverback Therapeutics, Inc.

Newsfile November 10, 2021

LAWSUITS FILED AGAINST RECAF, ONTF and SBTX - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS

Accesswire November 10, 2021

ROSEN, A LEADING LAW FIRM, Encourages Silverback Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - SBTX

PR Newswire November 9, 2021

SILVERBACK THERAPEUTICS, INC. (NASDAQ: SBTX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Silverback Therapeutics, Inc.

PR Newswire November 9, 2021

SBTX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 4, 2022 in the Class Action Filed on Behalf of Silverback Therapeutics, Inc. Limited Shareholders

Newsfile November 9, 2021

SHAREHOLDER ALERT: Robbins LLP Informs Investors that Silverback Therapeutics, Inc. (SBTX) is Being Sued for Misleading Investors

Business Wire November 9, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of EAR, TMC and SBTX

Accesswire November 9, 2021

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire November 9, 2021

SHAREHOLDER ALERT: HNST ONTF SBTX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Accesswire November 9, 2021